GlobeNewswire - Licensing Agreements http://www.10gbhost.com/RssFeed/subjectcode/25-Licensing%20Agreements/feedTitle/GlobeNewswire%20-%20Licensing%20Agreements Contains the last 20 releases newsdesk@globenewswire.com (NewsDesk) Thu, 04 Feb 2021 16:35:43 GMT webmaster@globenewswire.com (Webmaster) http://www.10gbhost.com/news-release/2021/02/04/2170185/0/en/Alphageneron-Pharmaceuticals-Signed-Exclusive-License-Agreement-With-Multimmune-GmbH-For-Natural-Killer-Cell-Platform-Therapy-Worldwide.html http://www.10gbhost.com/news-release/2021/02/04/2170185/0/en/Alphageneron-Pharmaceuticals-Signed-Exclusive-License-Agreement-With-Multimmune-GmbH-For-Natural-Killer-Cell-Platform-Therapy-Worldwide.html Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1st, 2020, for its clinical stage autologous Natural Killer (“NK”) cell therapy and companion diagnostic platform, for all fields worldwide.

]]>
Thu, 04 Feb 2021 16:35 GMT 2170185 en GlobeNewswire Inc. Alphageneron Pharmaceuticals Thu, 04 Feb 2021 16:36 GMT Licensing Agreements Biotech Pharma Oncology Research colorectal cancer lung cancer
http://www.10gbhost.com/news-release/2021/02/04/2170086/0/en/Amarillo-receives-License-to-Install-for-Posse.html http://www.10gbhost.com/news-release/2021/02/04/2170086/0/en/Amarillo-receives-License-to-Install-for-Posse.html TSX-V:AGC Other OTC:AGCBF CA02301T1084 Amarillo receives License to Install for Posse TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) -- State regulators have approved the Posse Gold Mine, said Amarillo Gold Corporation today after receiving the License to Install (LI) for its project on the Mara Rosa Property in Goiás, Brazil. The license permits the company to start construction.

]]>
Thu, 04 Feb 2021 14:40 GMT 2170086 en GlobeNewswire Inc. Amarillo Gold Corp. Thu, 04 Feb 2021 14:41 GMT Licensing Agreements Amarillo Gold Corporation Amarillo Amarillo Gold gold AGC social license LI license to install brazil undervalued gold company TSX
http://www.10gbhost.com/news-release/2021/02/03/2169085/0/zh-hant/%E5%A4%A9%E6%BC%94%E8%97%A5%E6%A5%AD%E5%AE%A3%E4%BD%88%E8%88%87-Exelixis-%E7%B0%BD%E8%A8%82%E5%90%88%E4%BD%9C%E8%A8%B1%E5%8F%AF%E5%8D%94%E8%AD%B0-%E5%85%B1%E5%90%8C%E9%96%8B%E7%99%BC%E5%85%B7%E6%9C%89%E6%9B%B4%E4%BD%B3%E5%AE%89%E5%85%A8%E6%80%A7%E5%92%8C%E6%9C%89%E6%95%88%E6%80%A7%E7%9A%84%E5%8E%9F%E5%89%B5%E6%96%B0%E5%9E%8B%E5%AE%89%E5%85%A8%E6%8A%97%E9%AB%94%E5%81%B6%E8%81%AF%E8%97%A5%E7%89%A9.html http://www.10gbhost.com/news-release/2021/02/03/2169085/0/zh-hant/%E5%A4%A9%E6%BC%94%E8%97%A5%E6%A5%AD%E5%AE%A3%E4%BD%88%E8%88%87-Exelixis-%E7%B0%BD%E8%A8%82%E5%90%88%E4%BD%9C%E8%A8%B1%E5%8F%AF%E5%8D%94%E8%AD%B0-%E5%85%B1%E5%90%8C%E9%96%8B%E7%99%BC%E5%85%B7%E6%9C%89%E6%9B%B4%E4%BD%B3%E5%AE%89%E5%85%A8%E6%80%A7%E5%92%8C%E6%9C%89%E6%95%88%E6%80%A7%E7%9A%84%E5%8E%9F%E5%89%B5%E6%96%B0%E5%9E%8B%E5%AE%89%E5%85%A8%E6%8A%97%E9%AB%94%E5%81%B6%E8%81%AF%E8%97%A5%E7%89%A9.html 天演藥業宣佈與 Exelixis 簽訂合作許可協議,共同開發具有更佳安全性和有效性的原創新型安全抗體偶聯藥物 Exelixis 將使用天演藥業自主研發及擁有精準掩蔽功能的安全抗體技術 (SAFEbody),共同開發創新的安全抗體偶聯藥物 (ADC),此安全抗體技術可以提高抗體偶聯藥物 (ADC) 的治療指數]]> Wed, 03 Feb 2021 13:24 GMT 2169085 zh-Hant GlobeNewswire Inc. Adagene, Inc. Wed, 03 Feb 2021 13:25 GMT Licensing Agreements http://www.10gbhost.com/news-release/2021/02/03/2168759/0/en/Artificial-Lung-Devices-Pipeline-Looks-Promising-a-Positive-Push-to-the-Market-Size-Growth-in-the-Future-estimates-DelveInsight.html http://www.10gbhost.com/news-release/2021/02/03/2168759/0/en/Artificial-Lung-Devices-Pipeline-Looks-Promising-a-Positive-Push-to-the-Market-Size-Growth-in-the-Future-estimates-DelveInsight.html Artificial Lung Devices Pipeline Looks Promising, a Positive Push to the Market Size Growth in the Future, estimates DelveInsight With 20+ key companies and 23+ pipeline devices in the horizon Artificial Lung Devices Pipeline Landscape presents quite an appealing picture for the coming decade. ]]> Wed, 03 Feb 2021 08:00 GMT 2168759 en GlobeNewswire Inc. DelveInsight Business Research LLP Wed, 03 Feb 2021 08:00 GMT Health Company Announcement Press releases Market Research Reports Licensing Agreements Artificial lung devices market Healthcare devices market Artificial lung devices Artificial lung Medtronic COVID-19 Abiomed http://www.10gbhost.com/news-release/2021/02/02/2168558/0/en/Medexus-Pharmaceuticals-and-medac-GmbH-enter-into-a-License-Agreement-for-First-in-Class-Conditioning-Agent-for-Hematopoietic-Stem-Cell-Transplantation-Treosulfan-in-the-United-Sta.html http://www.10gbhost.com/news-release/2021/02/02/2168558/0/en/Medexus-Pharmaceuticals-and-medac-GmbH-enter-into-a-License-Agreement-for-First-in-Class-Conditioning-Agent-for-Hematopoietic-Stem-Cell-Transplantation-Treosulfan-in-the-United-Sta.html TSX-V:MDP Other OTC:MEDXF Frankfurt:P731 CA58410Q2036 Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States Orphan Designated Drug with August 2021 PDUFA date

]]>
Tue, 02 Feb 2021 19:21 GMT 2168558 en GlobeNewswire Inc. Medexus Pharmaceuticals Inc Tue, 02 Feb 2021 19:21 GMT Health Licensing Agreements Product / Services Announcement
http://www.10gbhost.com/news-release/2021/02/02/2168331/0/en/Ocugen-and-Bharat-Biotech-Announce-Execution-of-Definitive-Agreement-for-the-Commercialization-of-COVAXIN-in-the-US-Market.html http://www.10gbhost.com/news-release/2021/02/02/2168331/0/en/Ocugen-and-Bharat-Biotech-Announce-Execution-of-Definitive-Agreement-for-the-Commercialization-of-COVAXIN-in-the-US-Market.html Nasdaq:OCGN US67577C1053 Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of COVAXIN? in the US Market MALVERN, Pa. and HYDERABAD, India, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, and Bharat Biotech, a global leader in vaccine innovation, today announced they have entered into a definitive agreement to co-develop, supply, and commercialize Bharat Biotech’s COVAXIN?, an advanced stage whole-virion inactivated COVID-19 vaccine candidate, for the United States market.

]]>
Tue, 02 Feb 2021 14:27 GMT 2168331 en GlobeNewswire Inc. Ocugen Tue, 02 Feb 2021 14:27 GMT Health Licensing Agreements covid-19 vaccine ocugen
http://www.10gbhost.com/news-release/2021/02/01/2167287/0/zh-hans/%E5%A4%A9%E6%BC%94%E8%8D%AF%E4%B8%9A%E5%AE%A3%E5%B8%83%E4%B8%8EExelixis%E7%AD%BE%E8%AE%A2%E5%90%88%E4%BD%9C%E8%AE%B8%E5%8F%AF%E5%8D%8F%E8%AE%AE-%E5%85%B1%E5%90%8C%E5%BC%80%E5%8F%91%E5%85%B7%E6%9C%89%E6%9B%B4%E4%BD%B3%E5%AE%89%E5%85%A8%E6%80%A7%E5%92%8C%E6%9C%89%E6%95%88%E6%80%A7%E7%9A%84%E5%8E%9F%E5%88%9B%E6%96%B0%E5%9E%8B%E5%AE%89%E5%85%A8%E6%8A%97%E4%BD%93%E5%81%B6%E8%81%94%E8%8D%AF%E7%89%A9.html http://www.10gbhost.com/news-release/2021/02/01/2167287/0/zh-hans/%E5%A4%A9%E6%BC%94%E8%8D%AF%E4%B8%9A%E5%AE%A3%E5%B8%83%E4%B8%8EExelixis%E7%AD%BE%E8%AE%A2%E5%90%88%E4%BD%9C%E8%AE%B8%E5%8F%AF%E5%8D%8F%E8%AE%AE-%E5%85%B1%E5%90%8C%E5%BC%80%E5%8F%91%E5%85%B7%E6%9C%89%E6%9B%B4%E4%BD%B3%E5%AE%89%E5%85%A8%E6%80%A7%E5%92%8C%E6%9C%89%E6%95%88%E6%80%A7%E7%9A%84%E5%8E%9F%E5%88%9B%E6%96%B0%E5%9E%8B%E5%AE%89%E5%85%A8%E6%8A%97%E4%BD%93%E5%81%B6%E8%81%94%E8%8D%AF%E7%89%A9.html 天演藥業宣布與Exelixis簽訂合作許可協議,共同開發具有更佳安全性和有效性的原創新型安全抗體偶聯藥物 Exelixis將使用天演藥業自主研發的擁有精準掩蔽功能的安全抗體技術(SAFEbody)共同開發創新的安全抗體偶聯藥物(ADC),安全抗體技術可以提高抗體偶聯藥物(ADCs)治療指數(Therapeutic Index)]]> Mon, 01 Feb 2021 13:05 GMT 2167287 zh-Hans GlobeNewswire Inc. Adagene, Inc. Mon, 01 Feb 2021 13:05 GMT Licensing Agreements http://www.10gbhost.com/news-release/2021/02/01/2167224/0/en/PharmaTher-Signs-Exclusive-Worldwide-License-Agreement-for-Patented-Microneedle-Delivery-Technology-to-Deliver-Ketamine.html http://www.10gbhost.com/news-release/2021/02/01/2167224/0/en/PharmaTher-Signs-Exclusive-Worldwide-License-Agreement-for-Patented-Microneedle-Delivery-Technology-to-Deliver-Ketamine.html CNSX:PHRM.CN CNSX:PHRM OTC Markets:PHRRF CA6525121043 PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine TORONTO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that PharmaTher has entered into an Exclusive Worldwide Patent and Know-how License Agreement (the “Agreement”) with The Queen’s University of Belfast (“QUB”) for the development and commercialization of a patented hydrogel-forming microneedle delivery technology developed by Professor Ryan Donnelly to support PharmaTher’s product and clinical development initiatives with ketamine.

]]>
Mon, 01 Feb 2021 12:59 GMT 2167224 en GlobeNewswire Inc. Newscope Capital Corporation Mon, 01 Feb 2021 12:59 GMT Licensing Agreements Health agreement
http://www.10gbhost.com/news-release/2021/01/28/2166305/0/en/Murphy-USA-and-Core-Mark-Renew-Strategic-Supply-Agreement.html http://www.10gbhost.com/news-release/2021/01/28/2166305/0/en/Murphy-USA-and-Core-Mark-Renew-Strategic-Supply-Agreement.html NYSE:MUSA US6267551025 Murphy USA and Core-Mark Renew Strategic Supply Agreement EL DORADO, Ark. and WESTLAKE, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Murphy USA Inc. (NYSE: MUSA) and Core-Mark Holding Company, Inc. (NASDAQ: CORE) announced today that they have entered into a new five year supply agreement whereby Core-Mark will continue to serve as the primary wholesale distributor to Murphy USA, delivering over 75% of the merchandise sold in their stores.

]]>
Thu, 28 Jan 2021 21:30 GMT 2166305 en GlobeNewswire Inc. Murphy USA Inc. Thu, 28 Jan 2021 21:30 GMT Licensing Agreements Partnerships Product / Services Announcement
http://www.10gbhost.com/news-release/2021/01/28/2165917/0/en/Black-Rock-Petroleum-Company-announces-site-inspection-and-due-diligence-review.html http://www.10gbhost.com/news-release/2021/01/28/2165917/0/en/Black-Rock-Petroleum-Company-announces-site-inspection-and-due-diligence-review.html Other OTC:BKRP US09225J1088 Black Rock Petroleum Company announces site inspection and due diligence review Los Angeles Ca, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Los Angeles, CA – January 28, 2021

Black Rock Petroleum announces site inspection and due diligence review of two hydrocarbon exploration licenses? in Far East? Region of Sakhalin Island, Russian Federation. ?


Black Rock Petroleum Company (OTC:BKRP), a Nevada corporation. announced today that it has approved a site inspection and due diligence review of two vast onshore oil and gas fields on Sakhalin Island in the Russian Federation.

]]>
Thu, 28 Jan 2021 14:00 GMT 2165917 en GlobeNewswire Inc. Black Rock Petroleum Thu, 28 Jan 2021 14:00 GMT Company Announcement Licensing Agreements Joint Venture Partnerships
http://www.10gbhost.com/news-release/2021/01/28/2165817/0/en/Eco-Innovation-Enters-Cannabis-Sector-by-Acquiring-Exclusive-Rights-to-Disruptive-Supercritical-Extraction-Technology-for-Bioactive-Compounds.html http://www.10gbhost.com/news-release/2021/01/28/2165817/0/en/Eco-Innovation-Enters-Cannabis-Sector-by-Acquiring-Exclusive-Rights-to-Disruptive-Supercritical-Extraction-Technology-for-Bioactive-Compounds.html OTC Markets:ECOX US27888Q1022 Eco Innovation Enters Cannabis Sector by Acquiring Exclusive Rights to Disruptive Supercritical Extraction Technology for Bioactive Compounds VAN NUYS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Eco Innovation Group, Inc. ("ECOX" or the "Company") (OTC:ECOX), an innovative company aggregating investments in new technologies that promote environmental and social well-being, and the advancement of green energy solutions, is excited to announce the signing of an exclusive license agreement (the “Agreement”) with Glytech, LLC (“Glytech”), a California-based producer of disruptive supercritical extraction technology for bioactive compounds.

]]>
Thu, 28 Jan 2021 13:00 GMT 2165817 en GlobeNewswire Inc. Eco Innovation Group, Inc. Thu, 28 Jan 2021 13:02 GMT Licensing Agreements cannibis new technology green tech renewable energy
http://www.10gbhost.com/news-release/2021/01/27/2165071/0/en/Motorsport-Games-and-the-ACO-Enhance-and-Extend-Le-Mans-Esports-Series-Joint-Venture.html http://www.10gbhost.com/news-release/2021/01/27/2165071/0/en/Motorsport-Games-and-the-ACO-Enhance-and-Extend-Le-Mans-Esports-Series-Joint-Venture.html Nasdaq:MSGM TEMP12345678 Motorsport Games and the ACO Enhance and Extend Le Mans Esports Series Joint Venture Ten Year Exclusive License for Video Games Now Part of this Joint Venture

]]>
Wed, 27 Jan 2021 13:30 GMT 2165071 en GlobeNewswire Inc. Motorsport Gaming US LLC Wed, 27 Jan 2021 13:30 GMT Joint Venture Licensing Agreements
http://www.10gbhost.com/news-release/2021/01/26/2164467/0/en/The-International-Chili-Society-Now-Accepting-Applications-for-2021-Sanctioning.html http://www.10gbhost.com/news-release/2021/01/26/2164467/0/en/The-International-Chili-Society-Now-Accepting-Applications-for-2021-Sanctioning.html The International Chili Society Now Accepting Applications for 2021 Sanctioning DALLAS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- After almost a year of postponing chili events and delaying certification of new ones, the International Chili Society (ICS) announced today that it is once again accepting applications for chili events seeking professional sanctioning for the 2021 season and beyond.

]]>
Tue, 26 Jan 2021 15:00 GMT 2164467 en GlobeNewswire Inc. International Chili Society Tue, 26 Jan 2021 15:00 GMT Arts & Entertainment Feature Article Food Licensing Agreements Press releases chili event chili cook off chili tasting world chili new events chili fest food fest sanctioning chili sanctioning
http://www.10gbhost.com/news-release/2021/01/25/2163525/0/en/Relief-Therapeutics-and-Acer-Therapeutics-Sign-Option-Agreement-for-Exclusivity-to-Negotiate-a-Collaboration-and-License-Agreement-for-the-Worldwide-Development-and-Commercializati.html http://www.10gbhost.com/news-release/2021/01/25/2163525/0/en/Relief-Therapeutics-and-Acer-Therapeutics-Sign-Option-Agreement-for-Exclusivity-to-Negotiate-a-Collaboration-and-License-Agreement-for-the-Worldwide-Development-and-Commercializati.html Nasdaq:ACER US00444P1084 Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the?Worldwide Development and Commercialization of ACER-001 for the Treatment of?Urea Cycle Disorders and Maple Syrup Urine Disease Acer to receive $1 million payment to obtain exclusivity and a $4 million loan from Relief

]]>
Mon, 25 Jan 2021 13:35 GMT 2163525 en GlobeNewswire Inc. Acer Therapeutics Inc. Mon, 25 Jan 2021 13:36 GMT Licensing Agreements
http://www.10gbhost.com/news-release/2021/01/25/2163450/0/en/BrainsWay-Signs-Exclusive-Distribution-Agreement-with-Gaelan-Medical-Trade-LLC.html http://www.10gbhost.com/news-release/2021/01/25/2163450/0/en/BrainsWay-Signs-Exclusive-Distribution-Agreement-with-Gaelan-Medical-Trade-LLC.html TASE:BWAY.TA Nasdaq:BWAY IL0011007189 BrainsWay Signs Exclusive Distribution Agreement with Gaelan Medical Trade LLC Following Historic Abraham Accords, Israel’s Deep Transcranial Magnetic Stimulation (Deep TMS) Treatment to Come to the United Arab Emirates]]> Mon, 25 Jan 2021 13:00 GMT 2163450 en GlobeNewswire Inc. Brainsway Ltd. Mon, 25 Jan 2021 13:01 GMT Licensing Agreements Product / Services Announcement http://www.10gbhost.com/news-release/2021/01/22/2163065/0/en/HCI-Group-Agrees-to-Acquire-Insurance-Business-in-Four-Northeast-States-from-United-Insurance-Holdings-Corp.html http://www.10gbhost.com/news-release/2021/01/22/2163065/0/en/HCI-Group-Agrees-to-Acquire-Insurance-Business-in-Four-Northeast-States-from-United-Insurance-Holdings-Corp.html NYSE:HCI US40416E1038 HCI Group Agrees to Acquire Insurance Business in Four Northeast States from United Insurance Holdings Corp. TAMPA, Fla., Jan. 22, 2021 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE: HCI), an InsurTech company with operations in insurance, software development and real estate, has entered into a renewal rights agreement, dated January 18, 2021, with United Insurance Holding Corp. (NASDAQ: UIHC) pursuant to which United is to transition to HCI all its personal lines insurance business in the states of Connecticut, New Jersey, Massachusetts and Rhode Island.

]]>
Fri, 22 Jan 2021 21:30 GMT 2163065 en GlobeNewswire Inc. HCI Group, Inc. Fri, 22 Jan 2021 21:30 GMT Company Announcement Licensing Agreements
http://www.10gbhost.com/news-release/2021/01/21/2161920/0/en/ViaDerma-Inc-Completes-a-Licensing-Agreement-with-a-Group-of-Affiliate-Wound-Care-Medical-Practices-Operating-in-Six-States.html http://www.10gbhost.com/news-release/2021/01/21/2161920/0/en/ViaDerma-Inc-Completes-a-Licensing-Agreement-with-a-Group-of-Affiliate-Wound-Care-Medical-Practices-Operating-in-Six-States.html Other OTC:VDRM US92555K1016 ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical practices. The medical practices provide advanced wound care treatment to homebound patients and are currently operating in six states. ViaDerma’s goal is to increase its presence to medical practices in sixteen states this year and to be in all fifty states by the end of 2022.

]]>
Thu, 21 Jan 2021 10:00 GMT 2161920 en GlobeNewswire Inc. ViaDerma Licensing Thu, 21 Jan 2021 10:00 GMT Licensing Agreements
http://www.10gbhost.com/news-release/2021/01/20/2161622/0/en/Canada-Coal-Announces-Ayurcann-Receipt-of-Amendment-to-Standard-Processing-Licence-to-Allow-for-Sales.html http://www.10gbhost.com/news-release/2021/01/20/2161622/0/en/Canada-Coal-Announces-Ayurcann-Receipt-of-Amendment-to-Standard-Processing-Licence-to-Allow-for-Sales.html TSX-V:CCK-H TSX-V:CCK Other OTC:CDCLF CA1348491087 Canada Coal Announces Ayurcann Receipt of Amendment to Standard Processing Licence to Allow for Sales THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

]]>
Wed, 20 Jan 2021 16:05 GMT 2161622 en GlobeNewswire Inc. Canada Coal Inc. Wed, 20 Jan 2021 16:05 GMT Health Licensing Agreements Product / Services Announcement
http://www.10gbhost.com/news-release/2021/01/20/2161371/0/en/Gritstone-and-Genevant-Sciences-Announce-License-Agreement-for-COVID-19-Vaccine.html http://www.10gbhost.com/news-release/2021/01/20/2161371/0/en/Gritstone-and-Genevant-Sciences-Announce-License-Agreement-for-COVID-19-Vaccine.html Nasdaq:GRTS US39868T1051 Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine — Deal provides nonexclusive access?to Genevant’s leading LNP technology for use in Gritstone’s self-amplifying RNA COVID-19 vaccine program; NIH-sponsored Phase 1 clinical trial expected to initiate in 1Q21

]]>
Wed, 20 Jan 2021 13:00 GMT 2161371 en GlobeNewswire Inc. Gritstone Oncology, Inc Wed, 20 Jan 2021 13:00 GMT Health Licensing Agreements
http://www.10gbhost.com/news-release/2021/01/19/2160529/0/en/Advaxis-Announces-Receipt-of-Funding-Milestone-Payment-Under-ADXS-HER2-Licensing-Agreement-with-OS-Therapies.html http://www.10gbhost.com/news-release/2021/01/19/2160529/0/en/Advaxis-Announces-Receipt-of-Funding-Milestone-Payment-Under-ADXS-HER2-Licensing-Agreement-with-OS-Therapies.html Nasdaq:ADXS US0076242082 Advaxis Announces Receipt of Funding Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies Non-dilutive capital strengthens balance sheet to further advance ADXS-HOT neoantigen program]]> Tue, 19 Jan 2021 13:00 GMT 2160529 en GlobeNewswire Inc. Advaxis, Inc. Tue, 19 Jan 2021 13:00 GMT Licensing Agreements
亚洲精品私拍国产在线播放_亚洲综合区图片小说区_亚洲日本欧美日韩高观看